MARA up +4.55% percent Today $MARA High is at 15.90 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 2:02 PM

MARA up +4.55% percent Today $MARA High is at 15.90 and the Low 14.91 with current volume of 75,197.

Recent News posted below.

Marathon Patent Group Inc. MARA other info.
http://investorshangout.com/Marathon-Patent-G...ARA-69068/

MARA Marathon Patent Group Inc. Recent Headline News

Update: Marathon Patent Group Reports Outstanding Q3 Revenues And Earnings
Mobile Guru - at Seeking Alpha - Thu Nov 13, 6:20AM CST

ACTG: 18.76 (unch), MARA: 14.34 (-0.16)

Marathon Patent EPS of $1.20
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:43PM CST

MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Strong Third Quarter 2014 Financial Results
Marketwired - Wed Nov 12, 3:06PM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon" or the "Company"

, a patent licensing company, announced today financial results for the third quarter ended September 30, 2014. Highlights included:
MARA: 14.34 (-0.16)

Marathon Patent Group Names Chief Technology Officer / Senior Vice President of Licensing and Senior Vice President of Licensing
Marketwired - Mon Nov 10, 12:03PM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that Umesh Jani and Rick Sanchez have been named to the Company's Executive Management Team as Chief Technology Officer / SVP of Licensing and Senior Vice President of Licensing, respectively.
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. to Announce Third Quarter 2014 Financial Results on November 12, 2014
Marketwired - Wed Nov 05, 8:01AM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that the Company will issue financial results for the third quarter ended September 30, 2014 after the market closes on Wednesday, November 12, 2014.
MARA: 14.34 (-0.16)

Marathon Patent Group Recently Acquired MedTech Patents Already Paying Dividends
Mobile Guru - at Seeking Alpha - Wed Nov 05, 7:31AM CST

MARA: 14.34 (-0.16)

Marathon Patent Group Wholly Owned Subsidiary MedTech Development Deutschland GmbH Receives Favorable First Instance Patent Infringement Ruling Against Stryker GmbH & Co. KG
Marketwired - Mon Nov 03, 10:20AM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on October 30, 2014, Marathon Patent Group wholly owned subsidiary MedTech Development Deutschland GmbH was notified that two favorable first instance patent infringement rulings have been issued involving the German parts of European patent EP 1 938 765 B1 and EP 1 104 260 B2 ('patents in dispute'

before the Duesseldorf District Court. The rulings include injunctive relief and damages, as well as the additional grant of claims for destruction of the infringing products and information on the distribution chain. Formal notification of the ruling is expected shortly.
MARA: 14.34 (-0.16)

Judge Issues Order in TLI Communications LLC Patent Litigation
Marketwired - Mon Oct 27, 7:31AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on October 16, 2014, Honorable United States District Judge T.S. Ellis, III, issued an order relating to all member cases in the TLI Communications LLC patent litigation.
MARA: 14.34 (-0.16)

Marathon Patent Group's Wholly-Owned Subsidiary Vantage Point Technology Inc. Files Patent Infringement Lawsuits Against Apple, Amazon, Box, Dropbox, Google and SugarSync
Marketwired - Wed Oct 22, 12:13PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that its wholly-owned subsidiary Vantage Point Technology Inc. ("Vantage Point"

, has filed patent infringement lawsuits against Amazon.com Inc., Apple, Inc., Box, Inc., Dropbox, Inc., Google Inc., and SugarSync, Inc. in the United States District Court for the Eastern District of Texas.
AMZN: 315.42 (+3.91), MARA: 14.34 (-0.16), GOOGL: 555.78 (-2.47), AAPL: 112.51 (+1.26)

White House nominates ex-Google patent counsel to head USPTO
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 1:24PM CDT

VRNG: 0.93 (-0.02), WILN: 3.38 (-0.02), ACTG: 18.76 (unch), MARA: 14.34 (-0.16), CRDS: 2.52 (-0.11), FNJN: 2.63 (-0.32), DSS: 0.51 (+0.04), VHC: 5.02 (+0.01)

Marathon Patent Group Completes Major Transaction for Significant Patent Assets and Accepts Subscriptions for $5.5 Million Financing
Marketwired - Mon Oct 13, 7:31AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) On October 10, 2014, Marathon Patent Group, Inc. ("Marathon"

entered into an interest sale agreement with MedTech Development, LLC. Pursuant to the Interest Sale Agreement, Marathon agreed to acquire from MedTech certain subsidiaries of MedTech consisting of 100% of the limited liability membership interests of OrthoPhoenix, LLC and TLIF, LLC as well as 100% of the shares of MedTech Development Deutschland GmbH. As a result, Marathon became the sole interest holder of OrthoPhoenix and TLIF as well as the sole shareholder and owner of MedTech GmbH. Each of the Subsidiaries owns certain medical technology patents, including pending litigation and settlement and licensing rights that are being acquired by the Company in the transaction.
MARA: 14.34 (-0.16)

CORRECTION - Marathon Patent Group Acquires TLI Communications LLC
Marketwire - Thu Sep 25, 10:08AM CDT
In the news release, "Marathon Patent Group Acquires TLI Communications LLC," issued earlier today by Marathon Patent Group (NASDAQ: MARA), we are advised by the company that the patent number in the first paragraph should read "6,038,295" rather than "6,3038,295" as originally issued. Complete corrected text follows.
MARA: 14.34 (-0.16)

Marathon Patent Group Acquires TLI Communications LLC
Marketwire - Thu Sep 25, 7:30AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that it has acquired TLI Communications LLC., owner of U.S. patent No. 6,3038,295 ('295 patent), which is an apparatus and method for recording, communicating and administering digital images.
FB: 74.13 (-0.59), MARA: 14.34 (-0.16)

Marathon Patent Group Receives Updated Analysis in New Report
Marketwire - Tue Sep 16, 11:50AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA), a patent licensing company, announced the commercial launch of its Opus Patent Analysis Platform this week. Marathon has received plenty of attention recently, and today, John H. Ford, who's been an active investor in the intellectual property space since he first invested in VirnetX four years ago, added to the growing interest with his update at Seeking Alpha.
MARA: 14.34 (-0.16)

Marathon Patent Group Names Daniel Gelbtuch Chief Marketing Officer
Marketwire - Tue Sep 16, 8:03AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that it has named Daniel Gelbtuch as its Chief Marketing Officer.
MARA: 14.34 (-0.16)

Marathon Announces Launch of Opus Patent Analysis Platform
Marketwire - Mon Sep 15, 8:01AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today the commercial launch of the Opus(TM) Patent Analysis Platform.
MARA: 14.34 (-0.16)

Marathon Patent Group Announces That USPTO Has Denied Arm Inc. Petition for Inter Partes Review of Vantage Point Patent
Marketwire - Mon Sep 08, 8:03AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on September 5, 2014, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) denied a petition for inter partes review (IPR) filed by Arm Inc. against Marathon subsidiary Vantage Point Technology's U.S. Patent No. 5,463,750 ('750 patent).
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Participation in Upcoming Investor Conferences
Marketwire - Thu Aug 28, 3:01PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA), a patent licensing company, announced today that the Company will participate in two upcoming investor conferences. The conference details are as follows:
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Second Quarter 2014 Financial Results
Marketwire - Thu Aug 14, 3:02PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon" or "The Company"

, a patent licensing company, announced today financial results for the second quarter ended June 30, 2014. Highlights included:
MARA: 14.34 (-0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Millrose Faces Securities Fraud Suit Amidst Decline

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Honeywell Aerospace Faces Class Action: Deadline Looms

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Think Together Marks 20 Years of ASES Impact in CA

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

HumanView Relaunch: LEAP Group Decodes Customer Signals

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Pathalys' Phase 3 Data Shows Promise for CKD Drug

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...